地塞米松在手术患者中的不良反应:Cochrane系统评价简版
本文为Cochrane系统评价简版,纳入37项RCT,评估成人手术患者围术期使用地塞米松的不良反应。结果显示地塞米松不增加术后伤口感染风险(Peto OR 1.01, 95%CI 0.80-1.27),对伤口愈合影响不明确,非糖尿病患者术后12小时内血糖轻度升高(平均差0.7 mmol/l, 95%CI 0.3-1.2)。
要点
- 地塞米松不增加术后伤口感染风险(中等质量证据)。
- 对伤口愈合的影响因置信区间宽而不明确(低质量证据)。
- 非糖尿病患者术后12小时内血糖轻度升高(低质量证据)。
核心结论
- 地塞米松未增加术后伤口感染风险,对伤口愈合影响不明确,非糖尿病患者术后12小时内血糖轻度升高。
研究设计与样本
- 系统评价与Meta分析,检索MEDLINE、Embase、Cochrane CENTRAL和Web of Science,纳入37项比较地塞米松与对照的RCT。
主要发现
- 伤口感染:Peto OR 1.01(95%CI 0.80-1.27),4603例参与者,26项研究,I²=32%,中等质量证据。
- 伤口愈合:Peto OR 0.99(95%CI 0.28-3.43),1072例参与者,8项研究,I²=0%,低质量证据。
- 非糖尿病患者术后12小时内血糖:平均差0.7 mmol/l(95%CI 0.3-1.2),595例参与者,10项研究,I²=50%,低质量证据。
临床怎么用
- 围术期使用地塞米松预防术后恶心呕吐时,无需过度担忧伤口感染风险。
- 对非糖尿病患者,术后12小时内应关注血糖轻度升高。
- 伤口愈合影响不明确,临床决策需结合个体情况。
局限性
- 伤口愈合和血糖结局的证据质量低。
- 血糖分析仅纳入非糖尿病患者,且异质性中等(I²=50%)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In the peri-operative period, dexamethasone is widely and effectively used for prophylaxis of postoperative nausea and vomiting. The objective of this meta-analysis was to assess the adverse effects of an incidental steroid load of dexamethasone in adult surgical patients. We searched in MEDLINE, Embase, the Cochrane Central Register of Controlled Trials and the Web of Science for randomised controlled trials comparing an incidental steroid load of dexamethasone with a control intervention in adult patients undergoing surgery. Two review authors independently screened studies for eligibility, extracted data and assessed all included studies for bias. Our primary outcomes were postoperative systemic or wound infection, delayed wound healing and glycaemic response within 24 h. We included 37 studies in this meta-analysis. The pooled results found no evidence that dexamethasone increased the risk of a postoperative wound infection, Peto OR (95%CI) 1.01 (0.80-1.27); 4603 participants, 26 studies; I² = 32%; moderate-quality evidence. Whether dexamethasone influenced wound healing was unclear due to the large confidence intervals, Peto OR (95%CI) 0.99 (0.28-3.43); 1072 participants, 8 studies; I² = 0%; low-quality evidence. Dexamethasone produced a mild increase in glucose levels among participants without diabetes during the first 12 h after surgery, mean difference (95%CI) 0.7 mmol.l-1 (0.3-1.2) 10 studies; 595 participants; I² = 50%; low-quality evidence. This article is an abridged version of a Cochrane Review.
引用
- Polderman JAW, Farhang-Razi V, van Dieren S, et al. Adverse side-effects of dexamethasone in surgical patients - an abridged Cochrane systematic review. Anaesthesia. 2019. PMID: 30821852. doi:10.1111/anae.14610
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。